Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032 Meeting Abstract
| Authors: | Sharma, P.; Siefker-Radtke, A. O.; de Braud, F.; Basso, U.; Calvo, E.; Bono, P.; Morse, M.; Ascierto, P. A.; Lopez-Martin, J.; Brossart, P.; Rohrberg, K. S.; Mellado, B.; Li, S.; Baudelet, C.; Unsal-Kacmaz, K.; Callahan, M. K.; Rosenberg, J. E. |
| Abstract Title: | Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032 |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S582 |
| End Page: | S583 |
| Language: | English |
| ACCESSION: | WOS:000573469101037 |
| DOI: | 10.1016/j.annonc.2020.08.821 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 749P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
